EverImmune (private company)

See something wrong or missing? Let us know
Offices:Paris
Business model:B2B

EverImmune is a biotech company developing treatments based on Oncobax AM, Akkermansia muciniphila, as a key bacterial commensal driving the clinical efficacy of anticancer therapeutics in cancer patients.

values in USD

Investments 5.71M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to EverImmune

Name Criteria
Spain Cebiotex
55%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Total raised in a similar range: 5M - 10M USD
France Cell-Easy
55%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Total raised in a similar range: 5M - 10M USD
Poland GeneMe
55%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Total raised in a similar range: 5M - 10M USD
Switzerland Rheon Medical
55%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Total raised in a similar range: 5M - 10M USD
Denmark Bactolife
55%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Total raised in a similar range: 5M - 10M USD
Sweden Intrance Medical Systems
55%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Total raised in a similar range: 5M - 10M USD
Italy Herbolea
55%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Total raised in a similar range: 5M - 10M USD
Denmark Bainan Biotech
50%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
Denmark Biograil
50%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
Germany Biomes
50%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
Top